Literature DB >> 25726992

Imaging coronary artery disease and the myocardial ischemic cascade: clinical principles and scope.

Matthias Renker1, Stefan Baumann2, Jeremy Rier3, Ullrich Ebersberger4, Stephen R Fuller3, Nicholas I Batalis5, U Joseph Schoepf6, Salvatore A Chiaramida7.   

Abstract

On a subcellular level, atherogenesis is characterized by the translocation of proatherogenic lipoproteins into the arterial wall. An inflammatory response involving complex repair mechanisms subsequently causes maladaptive vascular changes resulting in coronary stenosis or occlusion. The chronology of the underlying processes occurring from atherosclerosis to myocardial ischemia affect the selection and interpretation of diagnostic testing. An understanding of the ischemic cascade, atherosclerosis, coronary remodeling, plaque morphology, and their relationship to clinical syndromes is essential in determining which diagnostic modalities are useful in clinical practice.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Coronary artery disease; Ischemic cascade; Myocardial ischemia; Plaque vulnerability; Vascular remodeling

Mesh:

Year:  2015        PMID: 25726992     DOI: 10.1016/j.rcl.2014.11.010

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  3 in total

Review 1.  [Beyond Coronary CT Angiography: CT Fractional Flow Reserve and Perfusion].

Authors:  Moon Young Kim; Dong Hyun Yang; Ki Seok Choo; Whal Lee
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2022-01-21

Review 2.  Computed tomographic evaluation of myocardial ischemia.

Authors:  Yuki Tanabe; Akira Kurata; Takuya Matsuda; Kazuki Yoshida; Dhiraj Baruah; Teruhito Kido; Teruhito Mochizuki; Prabhakar Rajiah
Journal:  Jpn J Radiol       Date:  2020-02-05       Impact factor: 2.374

3.  Revisiting Application of Exercise Electrocardiography in Patients with Stable Ischemic Heart Disease.

Authors:  Jun Hyok Oh
Journal:  Korean Circ J       Date:  2020-05       Impact factor: 3.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.